Sprint Bioscience CEO Johan Emilsson comments on deal potential
The LSX Nordic Partnering and Investor Congress is in full swing in Copenhagen, and Sprint Bioscience is one of the attending companies. BioStock met with CEO Johan Emilsson and asked for his take on the market climate, the potential of preclinical partnering, and the development of the TREX-1 program.
00:00 Introduction
00:20 Current focus of Sprint Bioscience
01:03 Objective with LSX attendance
01:38 Early licensing opportunities
02:31 Interest in TREX-1
03:33 Navigating the current climate
05:15 Sprint Bioscience as an investment case
06:09 Aiming for break-even
06:36 What is the competition?
Subscribe and follow BioStock on:
YouTube https://bit.ly/Biostock
LinkedIn: / biostock
Facebook: / biostock.se
https://www.biostock.se/
#BioStock #LifeScience
About BioStock
BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies.